FemInEM
AdvocacySupport
Abortion access
Mifepristone safety and efficacy
Removal of rems restrictions
Citizen Petition from GenBioPro, Inc.
FDA-2025-P-2162-0001Other
Comments
120
Last activity Jul 1, 2026
Deadline
--
Net supportiSupport minus oppose · campaigns included
-58%
-58% excluding campaigns
Document
Details
The document's own metadata, straight from the source system.
- Title
- Citizen Petition from GenBioPro, Inc.
- Posted
- Jul 7, 2025
- Comment period
- Jul 7, 2025 – ?
- Topics
Analysis
Overview
What the public is saying — stance, who's commenting, and the issues they raise.
Include campaigns
Stance breakdown
-58%
Net support
Support22Oppose92Other6
Aggregates include form-letter campaigns. Excluding them, net support is -58% across organic comments.
Who commented
Breakdown by commenter type.
Academic
4
Business
6
Individual
76
Trade association
2
Advocacy
31
Other
1
Comments over time
Weekly arrivals, stacked by stance.
Posted Jul 7, 2025
Jul 21Aug 18Sep 8Oct 20Nov 17Jan 26Jun 29
Support22Oppose92Other6
Support × commenter type
How each type splits across stance.
Support
Oppose
Other
Individual
4%
88%
8%
Advocacy
32%
68%
0%
Business
83%
17%
0%
Academic
100%
0%
0%
Trade association
0%
100%
0%
Other
0%
100%
0%
Issues raised
The docket's canonical issues. Select one to browse its comments.
Position map
Who stands where on each issue?
Every non-silent position is backed by an excerpt from the comment.
Issues shown
Uncheck an issue to choose another.
| Organization | Abortion access | Mifepristone safety and efficacy | Removal of rems restrictions | Drug safety and efficacy | Impact on intimate partner violence |
|---|---|---|---|---|---|
FemInEM AdvocacySupport FemInEM, a non-profit organization focused on reproductive healthcare in emergency departments, supports the petition to | · | · |
7 organization-typed comments could not be identified.
Comments
Explorer
Every mirrored comment — filter by stance, campaign, or issue.
Filter:
- Jul 1, 2026Comment from FemInEMSupportAdvocacy📎 Attachment
FemInEM, a non-profit organization focused on reproductive healthcare in emergency departments, supports the petition to remove the Mifepristone Shared System REMS. They argue that mifepristone is safe and effective, and that emergency department visits following its use are often due to systemic healthcare barriers rather than medication safety concerns.
Read comment → - Oct 31, 2025Comment from Physicians for Human RightsSupportAdvocacy📎 Attachment
Physicians for Human Rights (PHR) supports the citizen petitions requesting that the FDA refrain from imposing additional restrictions on mifepristone. They argue that the drug is safe and effective based on extensive clinical evidence and that the review process should be grounded in scientific rigor rather than partisan politics.
Read comment → - Aug 18, 2025Comment from Joseph WitkusOtherIndividualRead comment →